Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions

Exclusion Criteria

• •Use of medications known to induce or inhibit drug-metabolizing enzymes within 30 days prior to the first dose, or other medications that may interfere with the study within 10 days prior to dosing.
• •Participation in another clinical trial involving an investigational product within 6 months prior to the first dose.
• •Whole blood donation within 8 weeks or component blood donation within 2 weeks prior to the first dose.
• •History of gastrointestinal resection that may affect drug absorption.
• •Known hypersensitivity to dutasteride, tamsulosin, or any component of the investigational product.
• •History of psychiatric illness, or any condition considered unsuitable for study participation by the investigator.